Anticorps Recombinant de lapin anti-CXCL13/BCA1

CXCL13/BCA1 Recombinant Antibody for WB, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

souris

Applications

WB, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

250336E12

N° de cat : 86564-1-PBS

Synonymes

Cxcl13, B lymphocyte chemoattractant, BCA1, Blc, CXC chemokine BLC



Informations sur le produit

86564-1-PBS cible CXCL13/BCA1 dans les applications de WB, Indirect ELISA et montre une réactivité avec des échantillons souris

Réactivité souris
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène CXCL13/BCA1 Protéine recombinante Eg3331
Nom complet chemokine (C-X-C motif) ligand 13
Masse moléculaire calculée12 kDa
Numéro d’acquisition GenBankNM_018866
Symbole du gène Cxcl13
Identification du gène (NCBI) 55985
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

CXCL13 (C-X-C motif chemokine 13), originally named B-lymphocyte chemoattractant (BLC) or B cell-attracting chemokine 1 (BCA-1), is a homeostatic chemokine that is constitutively secreted by stromal cells in the B-cell follicles of secondary lymphoid tissues (e.g., spleen, lymph nodes, tonsils, and Peyer's patches). It plays a crucial role in orchestrating cell migration within distinct regions of secondary lymphoid organs, strongly attracting B lymphocytes (and, to a lesser extent, T cells and macrophages) via its receptor CXCR5 (originally named Burkitt's lymphoma receptor 1, BLR1). In addition to maintaining immune cell trafficking and lymphoid follicle development, CXCL13 is implicated in inflammatory and autoimmune diseases (e.g., systemic lupus erythematosus, rheumatoid arthritis) and tumor progression (e.g., multiple myeloma).

{{ptg:RelatedPrimaryAntibodies}}